High cost of multiple sclerosis medicines is forcing many patients to take ‘drastic actions’
The high cost of multiple sclerosis treatments has forced 40% of patients to alter their use of the medicines, cutting back or skipping dosages altogether.
The high cost of multiple sclerosis treatments has forced 40% of patients to take “drastic actions” and alter their use of the medicines, such as cutting back or skipping dosages altogether. And many report the financial burden is not only hurting their lifestyle, but impairing their ability to save for retirement or college for their children, a new survey found.
For instance, 14% reported they switched to a generic, despite being satisfied with their existing treatment; 12% stopped using their medication for a period of time; 9% skipped or delayed filling a prescription; and 8% took less of their medicine than prescribed, according to the by the National Multiple
